Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 1;23(21):5855-9.
doi: 10.1016/j.bmcl.2013.08.098. Epub 2013 Sep 8.

New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases

Affiliations

New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases

Ke-Wu Yang et al. Bioorg Med Chem Lett. .

Abstract

In an effort to test whether a transition state analog is an inhibitor of the metallo-β-lactamases, a phospholactam analog of carbapenem has been synthesized and characterized. The phospholactam 1 proved to be a weak, time-dependent inhibitor of IMP-1 (70%), CcrA (70%), L1 (70%), NDM-1 (53%), and Bla2 (94%) at an inhibitor concentration of 100μM. The phospholactam 1 activated ImiS and BcII at the same concentration. Docking studies were used to explain binding and to offer suggestions for modifications to the phospholactam scaffold to improve binding affinities.

Keywords: Inhibitor; Metallo-β-lactamase; Phospholactam.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of β-lactam-containing antibiotics.
Figure 2
Figure 2
Structures of a hypothetical carbapenem transition state and β-phospholactam 1 synthesized in this study.
Figure 3
Figure 3
Complexes of NDM-1 co-crystalized with hydrolyzed β-lactams (A and C) and with the lowest-energy docked β-phospholactam 1 conformation (B and D). The coordinates of NDM-1 in panels A and B as well as hydrolyzed ampicillin in panel A are taken from PDB entry 4HL2. The coordinates of NDM-1 in panels C and D as well as hydrolyzed meropenem in panel C are taken from PDB entry 4EYL. The images were generated with VMD. The protein backbone is shown as a green cartoon and zinc ions as black spheres (Zn1 on the left and Zn2 on the right). The β hairpin loop in the back is loop 3; loop 10 was removed for clarity. The hydrolyzed substrates as well as the β-phospholactam 1 inhibitor and the Lys224 side chain are shown as sticks colored by atom (C, gray; O, red, N, blue; S, yellow; P, orange). Key distances summarized in Table 2 are indicated by dashed lines.
Scheme 1
Scheme 1
Synthetic route of β-phospholactam 1: a: (1) acetyl chloride, (2) Br2, (3) MeOH; b: benzylamine, K2CO3, CH3CN; c: NaBH4, EtOH; d: oxalyl chloride, DMSO, dichloromethane, −78 °C; e: dimethyl phosphonate, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), anhydrous THF; f: NaI, acetone; g: acetic anhydride, pyridine; h: Pd-C, H2; i: NaH, 15-crown-5, dichloromethane; j: LiOH, H2O, MeOH.

Similar articles

Cited by

References

    1. Mitcher LA, Lemke TL, Gentry EJ. In: Foye's Principles of Medicinal Chemistry. 6th ed. Lemke TL, Williams DA, Roche VF, Zito SW, editors. Wolters Kluwer Lippincott Williams & Wilkins; 2007.
    1. Bush K. Curr. Opin. Pharmacol. 2012;12:527. - PubMed
    1. Bush K, Macielag MJ. Expert Opin. Thera. Patents. 2010;20:1277. - PubMed
    1. Drawz SM, Bonomo RA. Clin. Microbiol. Rev. 2010;23:160. - PMC - PubMed
    1. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Antimicro. Agents Chemo. 2011;55:4943. - PMC - PubMed

Publication types

MeSH terms